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Abstract 
A combination of Langmuir isotherm, Brewster angle microscopy (BAM) and neutron 
reflectivity studies have been performed to gain insight into the effects on model bacterial 
cell membranes of the antimicrobial peptides, Rhesus -defensin 1 (RTD-1) and porcine 
protegrin 1 (PG-1). The peptides were interacted with monolayers spread at the air-water 
interface and prepared from a 3:1 molar mixture of phosphatidylethanolamine and 
phosphatidylglycerol - used to approximate the cell membranes of Gram positive bacteria. 
The Langmuir film balance measurements show that both peptides perturb the lipid 
monolayers causing an increase in surface pressure, and the BAM studies show that each 
results in the formation of small domains within the lipid films, around 5 m diameter. The 
overall change in monolayer surface pressure caused by PG-1, however, is a little more 
pronounced than that due to RTD-1 (+8.5 mN.m-1 vs. +5.5 mN.m-1), and the rate of its initial 
interaction with the monolayer is a little more rapid than that for RTD-1. The neutron 
reflectivity studies also show differences for PG-1 and RTD-1, with the model fits to these 
data showing that the more amphiphilic PG-1 becomes fully embedded within the lipid film 
– causing an extension of the lipid acyl chains but leaving the thickness of the lipid head 
group layer unaffected –  while RTD-1 is seen to insert less deeply – causing the same 
extension of the lipid acyl chains as PG-1 but also causing a significant increase in thickness 
of the lipid head group layer. The various differing effects of the two peptides on anionic 
lipid monolayers are discussed in the context of their differing haemolytic activities, and 
their proposed differing propensities to form transmembrane pores. 
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Introduction 
The rapid rise in the frequency of diagnosed microbial infections accompanied by the 
increased frequency with which these infections prove resistant1 to the existing arsenal of 
antibiotics has led to an urgent call for the development of new antimicrobial therapies2. 
The θ-defensins are seen as particularly promising in this respect2. These are newly 
discovered peptides that form part of the innate immune response3-6 in Old World monkeys 
and orangutans6,7. They are small, arginine rich, relatively inflexible peptides involving 18 
residues arranged with N-to-C-terminal main chain cyclization, and stabilised by three 
disulfide bridges5 (Figure 1). To date, there are two members of the family that have been 
characterized structurally, viz., Rhesus θ-defensin-1 (RTD-1)6 and retrocyclin-2 (HTD-2)8. The 
small size, high stability, and multiple host defence activities of the θ-defensins make them 
intriguing potential therapeutic agents5. 
Although there are no details yet available on the mode of action of these peptides, their 
close analogues, the protegrins, (which have a similar pattern of disulfide-links but no main 
chain cyclization) are suggested to form octameric pores in microbial membranes causing 
uncontrolled ion leakage, decay of transmembrane potential, loss of cell contents, and 
ultimately cell death9. Interestingly, however, the protegrins are shown to cause significant 
lysis of mammalian red blood cells, whereas the -defensins do not10. 
In the experiments reported here, we sought to use a combination of Langmuir isotherm, 
Brewster angle microscopy and neutron reflectivity studies to gain insight into the mode of 
action of the -defensins and the protegrins, with the specific aim to compare the manner 
in which these peptides interact with anionic lipid monolayers - which we use to 
approximate Gram positive bacterial cell membranes. 
The studies were conducted using synthetic porcine protegrin-1 (PG-1) and the acyclic (N- 
and C-terminally capped, but fully disulfide-linked) form of Rhesus –defensin-1 (aRTD-1) 
(see Figure 1), with the concentrations of each peptide (0.48 M) chosen according to their 
reported inhibitory potencies (viz., 0.1 – 1 M)10,11. The lipid monolayers used were 
prepared from a 3:1 molar mixture of phosphatidylethanolamine and phosphatidylglycerol 
which approximates the cell membranes of Gram positive bacteria12-13. 
  
Experimental 
Materials 
2-oleoyl-1-palmitoyl-sn-glycero-3-phospho-(1’-rac-glycerol) (h-POPG, C40H76O10P, Mw 
770.99 g mol-1), 2-oleoyl-1-d31-palmitoyl-sn-glycero-3-phospho-(1’-rac-glycerol) (palmitoyl 
chain deuterated POPG, d31-POPG, C40H45 D31O10P, MW 802.1 g mol-1), 2-oleoyl-1-palmitoyl-
sn-glycero-3-phosphoethanolamine (h-POPE C39H76NO8P Mw 718.01 g mol-1) and 2-oleoyl-1-
d31-palmitoyl-sn-glycero-3-phosphoethanolamine (palmitoyl chain deuterated POPE, d31-
POPE, C39H45 D31NO8P MW 749.2 g mol-1) were purchased from Avanti Polar Lipids 
(Alabaster, AL) and (after checking their purity by comparison of the measured Langmuir 
isotherms against those reported in the literature) were used as supplied. 
Protegrin 1 (PG-1; MW 2157.63 g mol-1) and acyclic Rhesus -defensin 1 (aRTD-1; Mw 
2100.62 g mol-1) were custom-synthesized to 99 % purity (as characterized by reverse phase 
HPLC and mass spectrometry; EZ Biolabs, Indiana, USA) and were used as received. aRTD-1 
has the same sequence and disulfide topology as the natural RTD-1 peptide but lacks main 
chain cyclisation and has its N- and C-termini capped by acetyl and amide groups, 
respectively. 
Ethanol, chloroform (spectroscopic grade) and D2O (99.9% deuteration) were purchased 
from Sigma Aldrich (Poole, Dorset, UK). Ultrapure water (with resistivity, 18.2 MΩ.cm at 
25°C) was obtained from a Millipore Milli-Q system (Millipore, Billerica, MA, USA). 
 
Surface-pressure area (π - A) isotherms 
Langmuir surface pressure measurements were recorded using a Nima Technologies 601 
Langmuir trough (Nima Technologies, Coventry, UK). After cleaning with copious amounts of 
water, followed by ethanol and then chloroform, the trough was filled with 130 mL 
ultrapure water. Lipid monolayers (POPE:POPG in 3:1 molar ratio) were spread onto the 
surface of the subphase from chloroform solution (at a concentration of 1 mg mL-1) using a 
Hamilton syringe (Bonaduz, Switzerland). The chloroform was allowed to evaporate for 10 
minutes after which time the resultant lipid monolayer was compressed (at 30 cm2 min-1) to 
determine the isotherm while continually recording surface pressure by means of a 
  
Wilhelmy plate (10 mm x 50 mm Whatman No. 1 filter paper; Whatman International, 
Maidstone, UK) partially submersed in the aqueous subphase. 
In order to establish the extent and kinetics of interaction of the anti-microbial peptides 
with the POPE:POPG monolayer, a lipid film was spread and compressed to a surface 
pressure of 25 mN m-1. The stability of the monolayer was subsequently confirmed by 
holding at constant area and monitoring for changes in surface pressure over a period of 30 
minutes. With the monolayer seen to be stable, an aqueous solution of PG-1 or aRTD-1 was 
systematically injected, slowly and evenly, into the aqueous sub-phase, such that the final 
concentration of peptide in the trough was 0.48 M. The surface pressure of the lipid film 
after injection of the peptide was then continuously monitored to ensure that any change in 
surface pressure due to the presence of the peptide had completed. In all cases, the time 
course of the interaction was found to be complete within ~90 minutes. 
All Langmuir film balance experiments were performed in triplicate using a freshly prepared 
monolayer each time. 
 
Brewster angle microscopy 
Brewster angle micrographs were obtained using a BAM2plus microscope (Nanofilm 
Technology, Goettingen, Germany) mounted above a Langmuir trough (Model 302m, Nima 
Technology Ltd, Coventry, UK) equipped with a surface pressure sensor. The microscope 
was equipped with a frequency doubled Nd:YaG laser (532 nm, 20 mW), polarizer, analyser 
and CCD camera. Lipid monolayers were deposited as described for the neutron reflectivity 
studies. Once equilibrated at 25 mN.m-1, an aqueous solution of anti-microbial peptide 
(either PG-1 or aRTD-1) was added to the subphase to give a subphase concentration of 0.48 
M. The surface pressure and film structure were then monitored for 3 hours following 
peptide addition. BAM images, taken at regular intervals following the peptide addition, 
were obtained using a 10x objective, providing a final magnification of x15, with image 
dimensions 392 μm by 503 μm. 
 
  
 
Neutron reflectivity studies 
Measurements of the monolayer neutron reflectivity, R(Q), were obtained as a function of 
the scattering vector, Q, (Å-1, Q = 4sin, where  is the neutron wavelength), and the 
data collected on the INTER reflectometer in TS2 at the STFC Rutherford Appleton 
Laboratory (Chilton, Oxfordshire, UK). Measurements were made with incident angles, θ = 
0.8° and 2.3°, giving a Q-range of 0.014 – 1 Å-1. (It should be noted here, however, that 
although the reflectivity  measured at Q < 0.03 Å-1 serves little benefit in modeling the 
structures of the various interfacial lipid and lipid/peptide layers, it does give confidence 
that the reflectivities are scaled correctly – as evidenced by the critical edge observed for 
D2O.) 
Instrument calibration was performed using a pure D2O subphase. For all systems studied, 
the neutron reflectivity measurements were recorded at 298 ± 2 K, and the data obtained 
under the three isotopic contrasts of: h-POPE:POPG monolayer on D2O, d-POPE/POPG 
monolayer on D2O, and d-POPE/POPG monolayer on null reflecting water (nrw; 92% v/v 
H2O:D2O). 
The neutron reflectivity experiments were performed under the same experimental 
conditions and using the sample environments as employed in the measurement of the 
surface pressure-area ( - A) isotherms. The POPE:POPG monolayer films were compressed 
at a rate of 30 cm2 min-1 to a surface pressure of 25 mN m-1 and the film then maintained at 
constant area for the duration of the reflectivity experiment. 
After measuring the reflectivity of each lipid film (and ensuring that it was fully consistent 
between the repeat experiments), the compressed monolayer was  maintained at the same 
area while constantly monitoring surface pressure, exposed to aRTD-1 or PG-1, and the 
reflectivity re-measured in 10 min time slices until it was clear that there were no further 
changes in reflectivity. The time for re-equilibration of the films after exposure to the 
antimicrobial peptides – as judged from the monitoring of the neutron reflectivity – was 
found consistent with that judged from the change in surface pressure, and was typically 
about 2 hours. After re-equilibration, the reflectivity profiles for the lipid films were 
recorded as previously. 
  
 
Neutron reflectivity data analysis 
Reflectivity data were reduced using Mantid14, and the reduced data analysed using the 
Abeles optical matrix methodology, with exploratory fits initially performed for the 
individual data sets using Afit (http://rkt.chem.ox.ac.uk/afit.html), and simultaneous 
refinements against all three contrasts subsequently carried out using Motofit 
(http://sourceforge.net/projects/motofit/). The scattering length densities and molecular 
volumes of materials are summarized in Table 1. For the peptides aRTD-1 and PG-1, the 
scattering length densities in nrw and D2O were computed on the basis of 46 and 51 
polar/exchangeable protons, respectively. Fits were performed assuming a Q-resolution of 
1%, and background scattering appropriate (and consistent) for the aqueous sub-phase 
under consideration (viz., ~4 x 10-6 Å-2 for D2O and ~6 x 10-6 Å-2 for nrw. 
The fitted scattering length density for each neutron contrast was related to the volume 
fractions of its various components as: 
Equation 1: 
 
where L is the fitted scattering length density of a given layer (Å-2), solvent, pep, and lipid 
are respectively the scattering length density of the solvent, peptide, and 3:1 POPE:POPG 
mixture (Å-2), and  are the corresponding component volume fractions. 
The interfacial molecular area for a given component (A, Å2) within a given layer was 
calculated as: 
Equation 2: 
 
where  and  are respectively the volume fraction of the component within the layer and 
its scattering length density, b is the sum of the component’s atomic scattering lengths (Å), 
and  is the fitted layer thickness (Å). The surface excess of peptide within a given layer (, 
mg.m-2) was obtained as: 
  
Equation 3: 
 
where MW is the relative molecular mass of the peptide and A its interfacial molecular area 
within the layer. 
The molecular volumes of aRTD-1 and PG-1 were computed from their relative molecular 
masses assuming a standard protein density15 of 1.37 g.cm-3. 
 
Results and Discussion 
Surface-pressure area (π - A) isotherms 
The isotherms recorded for the h- and d31-POPE/POPG monolayers (Figure 2a) exhibit no 
marked phase transition and are consistent with those reported by previous workers16. At a 
surface pressure of 25 mN.m-1 – as used in the subsequent neutron reflectivity experiments 
– both the h- and d31-POPE/POPG monolayers exist in an expanded phase with a mean 
interfacial molecular area (calculated from the isotherm) of a0 ~70 Å2. There are differences 
seen in the isotherms recorded for the h-lipid and d31-lipid films only when the films are 
highly compressed – when the mean interfacial area falls below 60 Å2 – and this is as might 
be expected given the subtle differences in inter-atomic interactions for protiated vs. 
deuterated alkyl chains17. 
With a 3:1 POPE/POPG monolayer compressed to a surface pressure of 25 mN.m-1 and then 
held at constant area, kinetic experiments following the addition of 0.48 M aRTD-1 into the 
sub-phase indicate an interaction of the peptide with the lipid film, with the addition 
causing an increase in surface pressure of around 5.5 mN.m-1, and film equilibrium re-
established roughly 2 hours post-injection (Figure 2b). The equivalent experiments 
performed for PG-1 (Figure 2c) also testify to an interaction of the peptide with the lipid 
film, with the surface pressure in this case changing by a total of about 8.5 mN.m-1, and the 
changes in the film again complete after roughly 2 hours. 
Comparable experiments reported for other anti-microbial peptides – albeit using 
monolayers with differing lipid compositions – give broadly similar results. The interactions 
  
of -purothionin and puroindoline-a with DPPG monolayers compressed to 22 mN.m-1, are 
shown (under the same conditions and using the same experimental set-up) to cause 
increases in surface pressure of 14 mN.m-1 and 10 mN.m-1, respectively, with the film re-
equilibrating in each case after about 3 hours18. Increases in surface pressure in the range 9 
– 20 mN.m-1 are reported for the interaction of melittin, magainin II and cecropin P1 with 
DPPG monolayers (compressed to 20 mN.m-1), with film equilibrium following interaction of 
all three of these peptides re-established after 1 – 3 hours19. The interaction of bactenecin20 
with a mixed DPPC/DPPG monolayer compressed to 25 mN.m-1 and that of dicynthaurin21 
with a DPPG monolayer compressed to 25 mN.m-1 result in surface pressure changes of +8 
mN.m-1 and +10 mN.m-1, respectively, with both of these changes complete within 1 – 2 
hours. It would thus appear that the overall changes in surface pressure induced by the 
various anti-microbial peptides are much the same, regardless of the exact composition and 
compression state of the anionic lipid monolayers, and also seemingly independent of the 
differing size and amphipathicity of the interacting peptides.  
From the surface pressure-time plots obtained following exposure of the monolayers to PG-
1 and aRTD-1, we do see, however, that there are differences in the kinetics of the initial 
interactions of these two peptides with the lipid monolayers, with the latter causing a 
change in surface pressure of ~3 mN.m-1 within the first half-hour following exposure, and 
aRTD-1 causing a change of only half this in the same time period. This difference in the 
initial rates of the two peptides’ interactions might perhaps be explained by the fact that 
PG-1 is significantly more amphiphilic than aRTD-1, and will thus more readily insert itself in 
the monolayer at the hydrophobe-head group (air-water) interface, whereas aRTD-1’s 
interaction with the monolayer will be dictated mainly by the electrostatic interaction 
between its multiple cationic side chains and the anionic groups in the monolayer, so that it 
associates – initially, at least –  only with the phospholipid head groups. 
The timescales of the events that conspire to account for the rather slow kinetics of the 
peptides’ interaction with the lipid monolayers and the long times taken subsequently for 
the monolayers to re-equilibrate, include the time taken for the peptides to diffuse to the 
interface from the bulk, the time required on their arrival at the interface to insert into the 
monolayer, and the time then required for them to re-arrange (both laterally and vertically) 
once inserted into the monolayer. 
  
Brewster Angle Microscopy 
In the absence of the antimicrobial peptides, the BAM images of the 3:1 POPE:POPG 
monolayers appear to show some form of liquid phase separation, with the film presenting 
as a raft of irregularly packed, roughly circular domains ranging in size from 10 – 50 m 
diameter (see Figure S1A, Supplementary Information). 
After exposure to aRTD-1 and PG-1 (the BAM images in these two cases appearing much the 
same), there are bright ~5 m domains that appear in the lipid film (see Figure S1B, 
Supplementary Information). It is impossible to determine the nature/composition of these 
domains from a simple inspection of the BAM images, but we speculate that they might 
perhaps be due to peptide aggregates formed within the monolayer, or they might arise as 
the result of a peptide-induced formation of condensed phase areas within the lipid film. 
The antimicrobial peptides clearly, therefore, introduce heterogeneity in the lipid films but 
it is important to note here that – from the point of view of the neutron reflectivity 
measurements – the sizes of these domains are significantly smaller than the neutron 
coherence length (viz., ~5 m vs. 20–40 m), and we can be confident, therefore, that any 
diffuse scattering that arises from the domains will make an insignificant contribution to the 
measured neutron specular reflection; the model fits to these data can thus be safely 
assumed to represent an average for the monolayer. 
 
Neutron reflectivity 
3:1 POPE:POPG monolayer structure 
Modelling of the reflectivity data for the 3:1 POPE:POPG monolayers was performed 
assuming a two-layer structure, with layer 1 (on the air-side) containing the lipid palmitoyl 
and oleoyl chains, and layer 2 (on the sub-phase side) containing the 
phosphatidylethanolamine (PE) and phosphatidylglycerol (PG) head groups. Fitting was 
performed with the scattering length densities for the two layers fixed as appropriate to 
these assumed lipid contents, and with optimization of the thickness and percent solvent in 
each of the layers, with the roughness at each interface set to zero. The final set of fitted 
parameter values are presented in Table 2.  
  
A mean interfacial molecular area of 70 ± 2 Å2 is calculated on the basis of the fitted layer 
thicknesses and scattering lengths, and this tallies with our own isotherm estimate of the 
area (vide supra), but is a little higher than the areas reported (on the basis of Langmuir film 
balance measurements) for 3:1 POPE:POPG monolayers by Picas et al.16 (68 Å2) and Suárez-
Germà et al.22 (66 Å2). 
The thickness of the lipid acyl chains layer (layer 1) was fitted as 13 ± 1 Å, and this compares 
favourably with the values quoted in the literature for POPC and POPG (in both cases, ~13.5 
Å)23,24. Assuming extended chain lengths of 16.4 Å and 15.9 Å for the C16:0 and C18:1 
chains, respectively, such a layer thickness indicates that the chains are tilted by around 35o 
– 37o with respect to the normal to the air-water interface. For comparison, we note that 
the chain tilts recorded by Huynh et al25 in their molecular dynamics simulations of POPC 
monolayers are in the range 35o – 43o. 
Our fitted PE/PG head group layer (layer 2) thickness is obtained as 9 ± 1 Å, and this is 
consistent with the layer thickness suggested by Kucerka et al23. The reflectivity-derived 
head group hydration is calculated as 7 H2O per lipid, and again this compares favourably 
with the experimentally determined figure of 9.4 H2O quoted for POPC by Kucerka et al23, 
and the figure of 6 – 7 H2O per lipid derived from molecular dynamics simulations of a 3:1 
POPE:POPG monolayer reported by Murzyn et al26. 
3:1 POPE:POPG monolayer structure after exposure to aRTD-1 and PG-1 
Simultaneous fittings of the reflectivity profiles obtained after exposure of the 3:1 
POPE/POPG monolayer to aRTD-1 and PG-1 were first performed using a three-layer model 
in which the values of the parameters for the first two layers were fixed as found for the 
monolayer before exposure to the peptides, and the scattering length density of the third 
layer fixed as calculated for the added peptide, and with simultaneous fitting of the 
reflectivity profiles performed with optimisation only of the thickness and solvent content 
of layer 3. These model fits, however, were found to be statistically very poor and/or 
physically unreasonable (data not shown).  
Two-layer (rather than three-layer) simultaneous fits were thus carried out in which the 
values of the parameters for layer 1 were fixed as obtained for the acyl chains layer (layer 1) 
in the monolayer prior to exposure to the peptides, and the parameters (of thickness, 
  
scattering length density, and solvent content) for the second (solvent-side) layer optimised 
in the fitting process. The resulting fitted parameter values for the monolayers exposed to 
aRTD-1 and PG-1 are both summarized in Table 2, and the fits to the reflectivity profiles for 
the monolayers before and after their exposure to aRTD-1 are shown in Figure 3. 
With these models, it was found that exposure of the monolayer to either of the two anti-
microbial peptides resulted in an increase in the thickness and water content of the lipid 
head group layer, with the magnitude of these changes different for PG-1 and aRTD-1, but 
with both peptides “associated with” ~6 lipid molecules. The greater increase in the 
thickness of layer 2 caused by aRTD-1 compared with that caused by PG-1 (+8.5 Å vs. +5.5 Å; 
Table 2) could perhaps be attributed to the greater rigidity of aRTD-1. It is less easy, 
however, to account for the differing effects of the two peptides on the level of monolayer 
hydration: PG-1 is seen to cause a smaller increase in the monolayer solvent content 
compared with that due to aRTD-1 (+6% vs. +17%; Table 2) and yet it has eight charged 
groups and a net charge at pH 7 of +6, while aRTD-1 has only 5 charged groups and a net 
charge of only +5 at pH 7. Moreover, on the basis of grazing incidence X-ray diffraction and 
specular X-ray reflectivity studies of compressed DPPG films, Neville et al have previously 
reported that PG-1 inserts into both the lipid head group and the acyl chains layers of a 
DPPG monolayer27. This observation was consistent with those reported by Ishitsuka et al – 
where (on the basis of Langmuir trough and fluorescence microscopy studies) PG-1 was 
shown to disturb the tail group packing and  by inference  to insert into the monolayers 
formed by DPPE and DPPG (at 25 mN/m)28. Similar models of peptide interaction with DPPG 
monolayers have also been reported by Clifton et al29 and Sanders et al30 in their neutron 
reflectivity studies of the membrane interactions of purothionin and puroindoline, and by 
Lad et al19 in their combined FTIR and neutron reflectivity study of melittin interaction with 
DPPG monolayers. (Attempts to improve these two-layer models by physically meaningful 
increases in the roughness of one or both of the layers proved unsuccessful.) 
Given the various findings reported by previous researchers, therefore, and despite the 
satisfactory quality of the data fits obtained with our two-layer modeling of the structures 
of the POPE/POPG monolayers after exposure to aRTD-1 and PG-1, we proceeded to 
perform further fitting of the reflectivity profiles – seeking consistency with the earlier 
results –  assuming the presence of peptide in both the acyl chains layer and the head 
  
groups layers in the monolayer. In these fits, the thickness, scattering length density, and 
solvent content of each of the two layers were optimized. 
These new fitted models were found to be different for the monolayer exposed to aRTD-1 
compared with that exposed to PG-1 and the fitted parameter values are summarized in 
Tables 3 and 4. Figure 4 shows the fitted neutron reflectivity data for the monolayer 
exposed to PG-1, and the volume fractions of the components of the layers after exposure 
to aRTD-1 and PG-1 are summarized in Table 5. 
Note here that the quality of these alternative two-layer fits is little different from that 
achieved with those performed assuming peptide only in the lipid head group region of the 
monolayer but they are preferred over our earlier models, in part because they are 
consistent with the findings reported by previous researchers27,28, and also because they 
account for the known differences in structures and biological properties of PG-1 and aRTD-
1 (see below). 
After exposure of the POPE/POPG monolayer to aRTD-1, there is a change in thickness seen 
for both the acyl chains layer (layer 1) and the head groups layer (layer 2), the former  
increasing by 3.6 Å, and the latter by 8.8 Å. There are changes too in the scattering length 
densities of the two layers, and these are consistent with peptide volume fractions of 0.15 
in layer 1 and 0.113 in layer 2. The volume fractions of lipid acyl chains in layer 1 is 0.85 and 
the volume fraction of lipid head groups in layer 2 is 0.187. The average interfacial 
molecular area of the lipid in the monolayer decreases from 70 Å2 (prior to exposure to the 
peptide) down to 64 Å2, and the percentage of solvent in the head group layer increases 
from 33% to 70%. The interfacial molecular areas and surface excesses of the peptide in 
layers 1 and 2 are 1004 Å2 and 0.34 mg.m-2, and 1221 Å2 and 0.29 mg.m-2, respectively. 
After exposure of the POPE/POPG monolayer to PG-1, the lipid acyl chains layer (layer 1) 
again increases in thickness from 13 Å to 16.5 Å, but the thickness of the head groups layer 
(layer 2) remains at 9 Å. The change in scattering length density observed for layer 1 
following exposure to PG-1, indicates volumes fractions of peptide and lipid in this layer of 
0.15 and 0.85, respectively, the areas per molecule for the lipid and peptide then obtained 
as 64 Å2 and 1038 Å2 – the latter indicating a PG-1 surface excess in layer 1 of 0.34 mg.m-2. 
In the head groups layer of the monolayer after exposure to PG-1, the volumes fractions of 
the lipid and peptide are obtained as 0.19 and 0.32, respectively, and these indicate areas 
  
per molecule of 64 Å2 for the lipid, and 865 Å2 for the PG-1, with a surface excess of PG-1 in 
this layer of 0.41 mg.m-2. As was found for the modelling of the reflectivity data assuming 
PG-1 penetration only into the lipid head group layer, this alternative modelling again shows 
an increase in the level of head group hydration that is significantly less than seen following 
exposure to aRTD-1 (increasing only to 49% rather than 70%). 
Regardless of whether the POPE/POPG monolayer is exposed to PG-1 or aRTD-1, therefore, 
we see that the acyl chains layer increases in thickness by around 3.5 Å, indicating that both 
peptides interact with the lipid film and cause the hydrocarbon chains to assume their fully 
extended length (~16 Å). The changes that are induced in the lipid head groups layer, 
however, are clearly very different for aRTD-1 and PG-1. While the former causes the head 
group layer to more-or-less double in thickness (increasing from 9 Å to 18 Å), the latter 
appears not to cause any increase in the head group layer thickness. For PG-1, therefore, it 
would seem that the peptide inserts fully into the monolayer and yet causes only a change 
in the lateral packing of the lipid molecules (with the result that the mean lipid interfacial 
area decreases from 70 Å2 to 64 Å2). In the case of aRTD-1, however, it would seem that the 
peptide inserts only partially into the lipid layer, causing the same reduction in the lipid 
interfacial area, but with a significant part of its structure protruding from the layer and 
lying within an extended head group layer. The scattering length density profiles calculated 
for the two peptide-exposed monolayers are shown in Figure 5A, and schematics of their 
molecular architectures are given in Figures 5B and 5C.  
The various differences that are observed here for the effects of PG-1 and aRTD-1 on anionic 
lipid monolayers are consistent with the reported differences in their hemolytic activities, 
and also with their proposed differing propensities for transmembrane pore formation. 
While both -defensin and its acyclic variant, aRTD-1, are shown to be essentially non-
hemolytic when tested at a concentration of 50 g.mL-1 (that is, a concentration of ~100 
M), PG-1, when tested at the same concentration, is reported to cause a complete loss of 
erythrocyte viability31. The more amphiphilic peptide, PG-1 – with its central -sheet having 
distinct hydrophilic and hydrophobic faces – inserts into the lipid monolayer positioning 
itself at the air-water interface such that its apolar leucine, tyrosine, phenylalanine and 
valine side chains lie within the lipid acyl chain region, and its cationic arginine side chains 
interacting with the anionic phosphates of the lipid head groups. In contrast, the relatively 
  
non-amphiphilic aRTD-1, which lacks any clear hydrophobic region, is unable to sit quite as 
favorably as PG-1 at the air-water interface, and so positions itself primarily within the lipid 
head group region, thereby causing the head groups to extend and orient themselves to lie 
more perpendicular to the interface. 
The observations recorded here are also consistent with the results obtained in molecular 
dynamics (MD) simulations32 of the antimicrobial peptides’ interactions with anionic 
membranes. These MD studies show that the membrane-embedded octameric -barrels of 
PG-1 are stable and persistent, causing a localized thinning of the membrane, and forming 
transmembrane pores of 2 nm inner and 4 nm outer radius. In contrast, the same oligomeric 
assemblies of RTD-1 are seen to be much less stable, becoming distorted over the course of 
the simulation and showing peptide molecules migrating out and away from the pore. 
  
Summary and Conclusions 
On the basis of the reported Langmuir film balance and neutron reflectivity studies, it is thus 
concluded that - despite their common classification as cationic -hairpin antimicrobial 
peptides - PG-1 and RTD-1 show significant differences in their interaction with anionic lipid 
monolayers. The more amphiphilic PG-1 appears to become deeply embedded within the 
anionic lipid monolayer while RTD-1 interacts in a relatively superficial manner, remaining 
much more intimately associated with the anionic lipid head groups. By extrapolation, it 
would thus seem reasonable to expect that while RTD-1 would show relatively little 
interaction with neutral/zwitterionic lipid membranes (as found in eukaryotic cell 
membranes), PG-1 would interact with this type of membrane much more strongly. We can 
thus account for the differences between the two peptides that are seen experimentally, 
with PG-1 recorded as haemolytic, and RTD-1, non-haemolytic31. 
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Figure Legends 
 
Figure 1 Primary structures of the RTD-1 peptide (upper panel) showing the 
characteristic θ-defensin structural motif: a cyclic peptide backbone cross-linked by three 
(Cys-Cys) disulfide bonds, and the porcine protegrin-1, PG-1, (lower panel) which shows 
significant primary structural homology but has only two disulfides and no main chain 
cyclisation. 
Figure 2 (A) Langmuir isotherms for 3:1 POPE:POPG monolayers spread at the air-
water interface. The isotherm for the d-lipid system is shown in black, and that for the h-
lipid system in red. (B) The change in surface pressure following addition of aRTD-1 to the h-
lipid film (compressed to 25 mN/m and then held at constant area). The arrow indicates the 
time of peptide addition. (C) The corresponding plot showing the change in surface pressure 
following addition of PG-1 to the h-lipid film. 
Figure 3 Neutron reflectivity data (shown as plots of R(Q).Q4 vs. Q) and associated 
model fits for 3:1 POPE:POPG monolayers spread at the air-water interface, before (filled 
symbols) and after (open symbols) exposure to 0.48 M aRTD-1. Data shown are for the 
three isotopic contrasts of d-POPE:POPG  ± aRTD-1 on D2O (A), d-POPE:POPG ± aRTD-1 on 
nrw (B), and h-POPE:POPG ± aRTD-1 on D2O (C). The structural parameters used in providing 
the model fits shown are summarised in Tables 2 and 3. 
Figure 4 Neutron reflectivity data (shown as plots of R(Q).Q4 vs. Q) and associated 
model fits for 3:1 POPE:POPG monolayers spread at the air-water interface after exposure 
to 0.48 M PG-1. Data shown are for d-POPE:POPG + PG-1 on D2O (filled circles), d-
POPE:POPG + PG-1 on nrw (open circles), and h-POPE:POPG + PG-1 on D2O (open triangles). 
The structural parameters used in the model fits shown are summarised in Table 4. 
Figure 5 (A) Scattering length density profiles for 3:1 d31-POPE: d31-POPG monolayers 
spread at the air-water interface and exposed to 0.48 M PG-1 (dotted line) and aRTD-1 
(solid line) (calculated on the basis of the neutron reflectivity model fits summarised in 
Tables 3 and 4). (B) Molecular model showing PG-1 inserted into a 3:1 POPE:POPG 
monolayer. The carbon atoms of the lipid acyl chains are shown in cyan, the peptide is 
  
shown in white but with the arginine side chain guanidinium groups highlighted in violet, 
and the phospholipid N, O and P atoms shown in blue, red, and yellow, respectively. (C) 
Molecular model showing aRTD-1 inserted into a 3:1 POPE:POPG monolayer. The atom 
colours are as detailed for (B). 
  
Table 1 
Scattering lengths (Σb), molecular volumes, and scattering length densities () of the 
molecular constituents of the various monolayers studied 
Molecule/ 
fragment Volume / Å
3 Scattering length density / 10-6 Å-2 
h-POPE:POPG 
acyl chains 909 -0.29 
d-POPE:POPG 
acyl chains 909 3.26 
POPE:POPG 
head groups 213 3.26 
aRTD-1 in D2O 2504 3.76 
aRTD-1 in nrw 2587 1.99 
PG-1 in D2O 2504 3.91 
PG-1 in nrw 2587 2.02 
 
 
  
Table 2 
Structural parameters obtained through simultaneous model fits to neutron reflectivity 
data obtained for 3:1 POPE:POPG monolayers at 25 mN.m-1 and 295 ± 2 K, before and 
after the injection of 0.48 M aRTD-1 and PG-1 into the aqueous sub-phase. 
 
 POPE:POPG POPE:POPG + aRTD-1 POPE:POPG + PG-1 
Layer 
1 
d† / Å 13 
 / 10-6 Å-2 3.26 (d31-lipids) -0.29 (h-lipids) 
% H2O 0 
Layer 
2 
d† / Å 9 17.5 14 
 / 10-6 Å-2 3.26 3.51 (D2O) 2.63 (nrw) 
3.68 (D2O) 
2.47 (nrw) 
% H2O 33 50 39 
 
† Layer thicknesses are given to the nearest 0.5 Å. 
  
Table 3 
Structural parameters obtained through simultaneous model fits to neutron reflectivity 
data obtained for 3:1 POPE:POPG monolayers at 25 mN.m-1 and 295 ± 2 K, after the 
injection of 0.48 M aRTD-1 into the aqueous sub-phase. 
 
3:1 POPE:POPG + aRTD-1 
 d31-lipids / D2O d31-lipids / nrw h-lipids / D2O 
Layer 
1 
d† / Å 16.5 
 / 10-6 Å-2 3.36 3.10 0.32 
% H2O 0 
Layer 
2 
d† / Å 18 
 / 10-6 Å-2 3.45 2.78 3.45 
% H2O 70 
 
† Layer thicknesses are given to the nearest 0.5 Å. 
 
  
Table 4 
Structural parameters obtained through simultaneous model fits to neutron reflectivity 
data obtained for 3:1 POPE:POPG monolayers at 25 mN.m-1 and 295 ± 2 K, after the 
injection of 0.48 M PG-1 into the aqueous sub-phase. 
 
3:1 POPE:POPG + PG-1 
 d31-lipids / D2O d31-lipids / nrw h-lipids / D2O 
Layer 
1 
d† / Å 16.5 
 / 10-6 Å-2 3.36 3.07 0.34 
% H2O 0 
Layer 
2 
d† / Å 9 
 / 10-6 Å-2 3.46 2.89 3.46 
% H2O 49 
 
† Layer thicknesses are given to the nearest 0.5 Å. 
 
  
Table 5 
Volume fractions of phospholipid, peptide and solvent in 3:1 POPE:POPG monolayers at 
25 mN.m-1 and 295 ± 2 K, after the injection of 0.48 M PG-1 and 0.48 M aRTD-1 into the 
aqueous sub-phase. 
 
 Volume fraction of layer after 
exposure to aRTD-1 
Volume fraction of layer after 
exposure to PG-1 
 P L S P L S 
Layer 1 0.15 0.85 0 0.15 0.85 0 
Layer 2 0.12 0.19 0.69 0.32 0.19 0.49 
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